FundedIQ
Biotechnology

Quanta Therapeutics: Funding, Investors & Team (Oct 2026)

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes. It develops allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types.

www.quantatx.com San Francisco, United States 11-50 employees
Biotechnology Health Care Medical Device Therapeutics
Total raised
$50.7M
Rounds
1
Latest
Series D
May 2023

Quanta Therapeutics has raised $50.7M across 1 funding round on record, the most recent a Series D of $50.7M announced in May 2023.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Quanta Therapeutics Company Profile and Key Stats

Total funding raised
$50.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series D
$50.7M in May 2023
Employees
11-50
reported band
Headquarters
San Francisco, United States

Latest funding round on record: May 2023.

Quanta Therapeutics Funding Rounds

Date
Round
Amount
Series D
$50.7M

Quanta Therapeutics Founders and Leadership Team

Name
Role
Contact
Cameron Pitt
Founder
Locked

Contact details for the Quanta Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Quanta Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
782
$99M

Quanta Therapeutics' latest round of $50.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Quanta Therapeutics in Biotechnology and San Francisco

Companies Similar to Quanta Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Quanta Therapeutics Funding FAQs

What does Quanta Therapeutics do?

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes. It develops allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types.

How much funding has Quanta Therapeutics raised?

Quanta Therapeutics has raised $50.7M across 1 round on record. The most recent is a Series D of $50.7M announced in May 2023.

When did Quanta Therapeutics last raise funding?

Quanta Therapeutics' most recent funding round on record is a Series D of $50.7M, announced in May 2023.

Who founded Quanta Therapeutics?

FundedIQ lists Cameron Pitt (Founder) at Quanta Therapeutics.

Where is Quanta Therapeutics headquartered?

Quanta Therapeutics is based in San Francisco, California, United States.

How many employees does Quanta Therapeutics have?

Quanta Therapeutics is in the 11-50 employee band.

How does Quanta Therapeutics' funding compare to other Biotechnology startups?

Quanta Therapeutics' latest round of $50.7M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Quanta Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Quanta Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.